DataMEDS AI, Inc. (NASDAQ: MEDS) has completed the acquisition of Helomics Corporation, an artificial intelligence cancer diagnostics laboratory, from Axe ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE